Vyne Therapeutics Inc
VYNE
$28.56+0.00%
Delayed · as of Oct 12, 2026, 11:31 AM ET
Mkt cap
$21.07M
EV/Sales
-5.19
P/E ratio
N/A
FY2025 Revenue
$570,000
EPS (H1 2026)
$-7.68
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-4646.14%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported VYNE revenue for 2025-12-31 was $570.0K. Net income was -$26.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. VYNE currently screens at market cap $21.1M.
Use this VYNE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VYNE income, balance, and cash tables.
Vyne Therapeutics Inc (VYNE) is a biotechnology company in the Healthcare sector.
Latest cached Vyne Therapeutics Inc (VYNE) revenue for Dec 31, 2025 was $570.0K. Net income was -$26.5M. Statements: https://lician.com/financials/vyne
Vyne Therapeutics Inc (VYNE) market capitalization is $21.1M on the latest cached snapshot.
Vyne Therapeutics Inc (VYNE) cached previous close $28.56; day range $23.37 – $28.56; volume 93,256. Session quote: https://lician.com/quote/vyne
Vyne Therapeutics Inc (VYNE) latest cached earnings event is "VYNE earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VYNE filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/vyne